From 7 till 9 November 2016 we will be attending BIO-Europe 2016 in Cologne (Germany). BIO-Europe is Europe’s largest partnering conference serving the global biotechnology industry. Our CEO Kees van der Graaf will be present on these days to talk about business opportunities.
Our main focus will be the prevention of Acute Kidney Injury with our SUL-138 compound. To advance the clinical trials we are looking for investors. Do you want to meet with Kees and discuss business? Please contact us.
More information about BIO-Europe can be found on the official BIO-Europe website.
Are you an investor and are you interested in our investment opportunities? Please click here!